:: Altroz - News Magazine HTML Template ::

Language:

biosimilar News

Biocon Biologics Secures Landmark Deal to Launch Yesafili, a Breakthrough Biosimilar, in the US Market

Sarah Mitchell 15 Apr, 2025

Biocon Biologics has reached a landmark agreement with Regeneron to commercialize Yesafili, a biosimilar to Eylea, in the US by 2026, following FDA approval. This deal resolves leg...

Business

Aurobindo Pharma's CuraTeQ Secures Positive EMA Opinion for Zefylti Biosimilar

Emily Rodriguez 17 Dec, 2024

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, received a positive opinion from EMA's CHMP for its filgrastim biosimilar, Zefylti. This marks the first biosimilar from Aurobi...